EAS at the European Society of Cardiology Congress in Amsterdam, August 25-28

EAS-ESC Joint Session at the ESC Congress 2023:
Risk Factors and Prevention, August 25, 16.30-17.30 CET


Kausik K Ray (Imperial College London – London, United Kingdom of Great Britain & Northern Ireland)  ProfKausikRay Marianne Benn (Rigshospitalet – Copenhagen University Hospital – Copenhagen, Denmark)

More on the session

To understand how elevated lipoproteins contribute to increased cardiovascular risk – as well as the role of triglycerides, triglyceride-rich lipoproteins, and lipoprotein(a) – and to be aware of strategies to bring lipids down to guideline-recommended levels in patients at high risk of cardiovascular events.


What are the unmet needs for lipid-lowering in the population? Speaker: Maciej Banach (Medical University of Lodz – Lodz, Poland)  maciejbanach Time: 16:30

New therapies to lower LDL-C: how to choose? Speaker: Lale Tokgozoglu (Hacettepe University – Ankara, Türkiye)  laletokgozoglu Time: 16:42

Are triglycerides and triglyceride-rich lipoproteins still relevant? Speaker: Erik Stroes (Academic Medical Centre – Amsterdam, Netherlands (The)) Time: 16:54

Why measure Lp(a) and what to do about it? Speaker: Florian Kronenberg (Medical University of Innsbruck – Innsbruck, Austria)  KronenbergLab Time: 17:06

Targeting the spectrum of atherogenic lipoproteins: what to do and how to do it – discussion Discussant: Paul M Ridker (Brigham and Women’s Hospital – Boston, United States of America) Time: 17:18

EAS Booth at ESC